CSIMarket Company Name, Ticker, Suppliers, else..
 
Astria Therapeutics Inc   (NASDAQ: ATXS)
 

Astria Therapeutics Inc's Suppliers Performance

ATXS's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ATXS Costs vs Sales of Suppliers Growth

• More on ATXS Suppliers






Astria Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party contract manufacturers for the production, packaging, labeling, and distribution of navenibart, STAR-0310, and other development candidates. This approach will continue to support their nonclinical, clinical, and commercial requirements. Third-party manufacturers are also responsible for producing the drug-device combination product for navenibart. The company does not intend to establish its own clinical or commercial manufacturing facilities and employs qualified personnel to manage relationships with contract development and manufacturing partners. These manufacturers are required to comply with current good manufacturing practices (cGMPs) and relevant laws and regulations. Additionally, the company has implemented inventory management and warehousing practices to reduce supply chain risks associated with the manufacture of navenibart and STAR-0310.

Astria Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party contract manufacturers for the production, packaging, labeling, and distribution of navenibart, STAR-0310, and other development candidates. This approach will continue to support their nonclinical, clinical, and commercial requirements. Third-party manufacturers are also responsible for producing the drug-device combination product for navenibart. The company does not intend to establish its own clinical or commercial manufacturing facilities and employs qualified personnel to manage relationships with contract development and manufacturing partners. These manufacturers are required to comply with current good manufacturing practices (cGMPs) and relevant laws and regulations. Additionally, the company has implemented inventory management and warehousing practices to reduce supply chain risks associated with the manufacture of navenibart and STAR-0310.







ATXS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Astria Therapeutics Inc 729.71 0.00 -124.03 14
SUBTOTAL 0.00 0.00 0.00 -


Sources: Astria Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Astria Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.